These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33039223)

  • 1. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraventricular tachyarrhythmias that responded dramatically to bisoprolol transdermal patches in two patients undergoing hemodialysis.
    Matsumoto T; Tamiya E; Yamamoto S; Kamiyama T; Takabe T; Kanoh T; Daida H
    Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12660. PubMed ID: 31190422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing postoperative atrial fibrillation after open-heart surgery using transdermal β
    Yamamoto K; Miwa S; Yamada T; Setozaki S; Hamuro M; Kurokawa S; Enomoto S
    J Cardiothorac Surg; 2023 Apr; 18(1):103. PubMed ID: 37024987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
    Toda H; Nakamura K; Shimizu K; Ejiri K; Iwano T; Miyoshi T; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Hikasa Y; Hayashi M; Morita H; Morimatsu H; Ito H;
    Circ J; 2020 Mar; 84(4):642-649. PubMed ID: 32092717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
    Yamamoto K; Yamada T; Hamuro M; Kawatou M; Enomoto S
    Kyobu Geka; 2017 Nov; 70(12):971-977. PubMed ID: 29104194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Sano T; Ikeda T
    Clin Exp Hypertens; 2020 Aug; 42(6):539-544. PubMed ID: 32009474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
    Yamashita T; Inoue H
    J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients.
    Yasui T; Oka T; Shioyama W; Oboshi M; Fujita M
    SAGE Open Med; 2020; 8():2050312120907817. PubMed ID: 32128207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of bisoprolol in patients with chronic heart failure.
    Nikolic VN; Jevtovic-Stoimenov T; Velickovic-Radovanović R; Ilic S; Deljanin-Ilic M; Marinkovic D; Apostolović S; Stanojevic D; Zivanovic S; Stefanovic N; Pesic S; Zecevic DR; Milovanovic JR; Jankovic SM
    Eur J Clin Pharmacol; 2013 Apr; 69(4):859-65. PubMed ID: 23093041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction.
    Godo S; Kawazoe Y; Ozaki H; Fujita M; Kudo D; Nomura R; Shimokawa H; Kushimoto S
    Intern Med; 2017 Oct; 56(19):2603-2609. PubMed ID: 28883252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
    Rau T; Düngen HD; Edelmann F; Waagstein F; Lainščak M; Dimković S; Apostolović S; Nešković AN; Haverkamp W; Gelbrich G; Eschenhagen T
    Clin Pharmacol Ther; 2012 Jul; 92(1):21-8. PubMed ID: 22617224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.